Exicure, Inc. Announces Participation in Upcoming Conferences
June 03 2021 - 7:00AM
Business Wire
Exicure, Inc.® (NASDAQ: XCUR), a pioneer in gene regulatory and
immunotherapeutic drugs utilizing spherical nucleic acid (SNA™)
technology, today announced that CEO David Giljohann will
participate in the following upcoming conferences:
BIO Digital 2021 Format:
Corporate update presentation Date: June 10, 2021
Time: 7:00 AM ET Location: The presentation will be
available to registered conference attendees for on-demand viewing
beginning June 10, 2021 at 7:00 AM ET via the virtual conference
link and will be archived for 90 days on Exicure’s website
following the conference.
BMO Biopharma Day: Spotlight on Rare
Disease and Ophthalmology Format: Rare Disease Panel:
Central Nervous System Date: June 22, 2021 Time:
10:30 AM ET Location: The panel discussion will be available
for live streaming to conference attendees at the virtual
conference link.
About Exicure, Inc.
Exicure, Inc. is a clinical-stage biotechnology company
developing therapeutics for neurology, immuno-oncology,
inflammatory diseases and other genetic disorders based on its
proprietary Spherical Nucleic Acid, or SNA technology. Exicure
believes that its proprietary SNA architecture has distinct
chemical and biological properties that may provide advantages over
other nucleic acid therapeutics and may have therapeutic potential
to target diseases not typically addressed with other nucleic acid
therapeutics. Exicure is in preclinical development of XCUR-FXN a
lipid-nanoparticle SNA–based therapeutic candidate, for the
intrathecal treatment of Friedreich’s ataxia (FA). Exicure’s
therapeutic candidate cavrotolimod (AST-008) is in a Phase 1b/2
clinical trial in patients with advanced solid tumors. Exicure is
based in Chicago, IL and in Cambridge, MA.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210603005227/en/
Media: Karen Sharma MacDougall 781-235-3060
ksharma@macbiocom.com
Exicure (NASDAQ:XCUR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Exicure (NASDAQ:XCUR)
Historical Stock Chart
From Jul 2023 to Jul 2024